Antibody-drug Conjugates Market Research and New Development 2021 to 2026

Global Antibody-drug Conjugates Market Size, Status And Forecast 2021-2026

The Antibody-drug Conjugates Market report provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments, and focuses on market, capacities and technologies and on the changing structure of the Antibody-drug Conjugates.

The global Antibody-drug Conjugates market is valued at 2646.2 million US$ in 2020 and is expected to reach 3262.1 million US$ by the end of 2026, growing at a CAGR of 3.0% during 2021-2026.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.

Request a Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/01031710264/global-antibody-drug-conjugates-market-research-report-2020/inquiry?source=openpr&Mode=07 

The Prominent Key Players of the Antibody-drug Conjugates Market:

ImmunoGen, Seattle Genetics, Roche, Takeda and others.

The competitive market players are identified along with their size, share, and strategies. The company profiles of these players, which includes their recent major developments, product portfolio, revenue, core competencies, and financials. Additionally, the report presents insights into the mergers & acquisitions, company profiles, financial status, product portfolio, and the SWOT analysis.

Recent Developments:

June 04, 2020 - LegoChem Biosciences, Inc. (LCB) has announced a worldwide license agreement with Iksuda Therapeutics for the development and commercialization of LCB73, a CD19-targeted ADC candidate for hematological tumors.

Under the terms of the agreement, Iksuda will make an upfront payment of USD 5 million and LCB is eligible to receive development, regulatory and commercial milestone payments of up to USD 222 million as well as royalties on commercial sales. LCB is also entitled to receive a prearranged percentage of sublicense revenue if Iksuda enters into license agreement with third party companies. All payments will be shared with LCB’s partner Light Chain Bioscience (Novimmune SA).

June 11, 2020 - AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest strategic alliance in European biotech in 2020. The partners aim to commercialize three phase I-stage antibody drugs for undisclosed types of solid and liquid cancer.

May 18, 2020 - AstraZeneca antibody-drug conjugate nabs accelerated review in U.S. for lung cancer

The FDA grants Breakthrough Therapy status for AstraZeneca's (NYSE:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of patients with metastatic HER2-positive non-small cell lung cancer (NSCLC) who have progressed on or after platinum-based chemo.

Interim data from a Phase 2 clinical trial, DESTINY-Lung01, will be virtually presented at ASCO at the end of the month.

Global Antibody-drug Conjugates Market Split by Product Type and Applications:

This report segments the global Antibody-drug Conjugates market on the basis of Types are:
Adcetris
Kadcyla

On the basis of Application, the Global Antibody-drug Conjugates market is segmented into:
Breast Cancer
Lymphoma

Ask For Discount:

https://www.marketinsightsreports.com/reports/01031710264/global-antibody-drug-conjugates-market-research-report-2020/discount?source=openpr&Mode=07 

Highlights of the Antibody-drug Conjugates Market Report:

- Accurate market size and CAGR forecasts for the period 2021-2026
- Identification and in-depth assessment of growth opportunities in key segments and regions
- Detailed company profiling of top players of the global Antibody-drug Conjugates market
- Exhaustive research on innovation and other trends of the global Antibody-drug Conjugates market
- Reliable industry value chain and supply chain analysis
- Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

The research includes historic data from 2015 to 2020 and forecasts until 2026 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Browse Full Report at:

https://www.marketinsightsreports.com/reports/01031710264/global-antibody-drug-conjugates-market-research-report-2020?source=openpr&Mode=07 

We also offer customization on reports based on specific client requirement:

1- Free Country level analysis for any 5 countries of your choice.
2- Free Competitive analysis of any 5 key market players.
3- Free 40 analyst hours to cover any other data points

Browse Related Reports:

Global Adcetris Market Research Report 2021

https://www.marketinsightsreports.com/reports/03012653227/global-adcetris-market-research-report-2021?source=openpr&Mode=07 

Kadcyla - Drug Insight And Market Forecast - 2030

https://www.marketinsightsreports.com/reports/03112693183/kadcyla-drug-insight-and-market-forecast-2030?source=openpr&Mode=07

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.